AGNCM AGNC Investment Corp. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
AGNCM Stock | Fundamental Analysis & Investment Insights
NASDAQ
Real Estate
REIT - Mortgage
Current Price
Live
$24.99
52W High
$25.49
52W Low
$23.01
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Feb 07, 2026
Market cap
$8.88B
P/E
N/A
ROE
15.1%
Profit margin
92.9%
Debt/Equity
6.89
Dividend yield
8.91%
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
AGNCM's deterministic health scores are deeply concerning: a Piotroski F-Score of 2/9 signals severe financial distress, and the absence of an Altman Z-Score with a Debt/Equity ratio of 6.89 and current/quick ratios below 0.2 indicate extreme liquidity and solvency risk. Despite impressive revenue and earnings growth (546% and 776% YoY), these gains are likely driven by one-time or non-recurring factors given the implausibly high margins (Profit Margin 92.93%, Gross Margin 100%) and lack of meaningful cash flow data. The stock trades at a premium valuation (Price/Book 2.66) with no intrinsic value or Graham Number, suggesting overvaluation. The 8.91% dividend yield is unsustainable given the weak financial health and lack of earnings visibility.
Key Strengths
Exceptional revenue and earnings growth (546.10% and 775.90% YoY)
High gross and operating margins (100.00% and 95.88%)
Strong historical price appreciation (50.8% 5Y, 43.9% 3Y)
High dividend yield (8.91%) attracting income investors
Significant market cap ($8.88B) indicating institutional presence
Key Risks
Piotroski F-Score of 2/9 indicates severe financial distress and poor operational health
Debt/Equity ratio of 6.89 is extremely high, signaling over-leverage
Current and quick ratios of 0.18 and 0.17 suggest acute liquidity risk
No available cash flow or debt figures raise concerns about financial transparency
Graham Number and Intrinsic Value are unavailable, indicating no fundamental valuation anchor
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
36
Weak
20
65
50
15
30
AI Verdict
High Risk
Key drivers: Extremely low Piotroski F-Score (2/9), Absence of Altman Z-Score with high leverage and low liquidity, Unsustainable margin levels, Lack of cash flow and debt transparency, Premium valuation without earnings support
Confidence
90%
Value
20/100
Ref P/E, PEG, Graham Number
Positives
- High dividend yield (8.91%) may appeal to income-focused investors
Watchpoints
- No Graham Number or intrinsic value estimate available
- Price/Book of 2.66 is elevated for a company with weak financial health
- No cash flow data to support valuation
- Revenue and earnings growth may not be sustainable
- High P/B suggests overvaluation relative to book value
Future
65/100
Ref Growth rates
Positives
- Exceptional YoY revenue and earnings growth (546% and 776%)
- Strong 5-year and 3-year price performance (+50.8% and +43.9%)
- High Q/Q earnings growth (682%) suggests momentum
Watchpoints
- Growth rates are likely unsustainable due to implausibly high margins
- No forward guidance or analyst coverage to validate future trajectory
- No free cash flow data to support reinvestment or dividend sustainability
Past
50/100
Ref Historical trends
Positives
- Consistent price appreciation over 5 and 3 years
- Stable trading range near 52-week high ($25.49)
Watchpoints
- Piotroski F-Score of 2 indicates deteriorating fundamentals over time
- High debt and low liquidity ratios suggest long-term structural weakness
- Profit margins are implausibly high (100% gross margin), raising red flags
Health
15/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- High ROE (15.08%) suggests some return efficiency
Watchpoints
- Piotroski F-Score of 2/9 is a critical red flag for financial health
- No Altman Z-Score available, but Debt/Equity of 6.89 and current ratio of 0.18 indicate distress risk
- ROA of 1.64% is low for a company with such high leverage
- Lack of cash flow and debt data prevents full health assessment
- High leverage with low liquidity suggests high default risk
Dividend
30/100
Ref Yield, Payout
Positives
- High dividend yield (8.91%) is attractive to income investors
Watchpoints
- Payout ratio is unavailable, but earnings are likely not sustainable
- Financial health is weak, making dividend coverage questionable
- No historical payout consistency data available
- High leverage and low cash flow suggest dividend may be at risk
- Dividend strength score of 40/100 reflects moderate sustainability
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$24.99
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for AGNCM and closest competitors.
Updated 2026-02-06
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
AGNCM
AGNC Investment Corp.
Primary
|
+50.8% | +43.9% | +8.8% | +4.0% | +1.4% | +0.1% |
|
AGNCN
AGNC Investment Corp.
Peer
|
+59.8% | +38.1% | +9.7% | +4.2% | +1.2% | +0.2% |
|
AHR
American Healthcare REIT, Inc.
Peer
|
+278.7% | +278.7% | +65.4% | +25.2% | -4.0% | -3.7% |
|
ADC
Agree Realty Corporation
Peer
|
+38.9% | +12.4% | +5.9% | +0.8% | +0.6% | -0.9% |
|
BRX
Brixmor Property Group Inc.
Peer
|
+90.8% | +33.3% | +5.2% | +5.4% | +1.4% | -1.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
2.66
P/S Ratio
4.94
EV/Revenue
54.4
EV/EBITDA
N/A
Market Cap
$8.88B
Profitability
Profit margins and return metrics
Profit Margin
92.93%
Operating Margin
95.88%
Gross Margin
100.0%
ROE
15.08%
ROA
1.65%
Growth
Revenue and earnings growth rates
Revenue Growth
+546.1%
Earnings Growth
+775.9%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
+682.0%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
6.89
High debt
Current Ratio
0.18
Weak
Quick Ratio
0.17
Poor
Cash/Share
$15.56
Real Estate Sector Comparison
Comparing AGNCM against 56 companies in the Real Estate sector
(1 bullish, 9 neutral, 46 bearish)
Return on Equity (ROE)
15.08%
This Stock
vs
-75.75%
Sector Avg
-119.9%
(Below Avg)
Profit Margin
92.93%
This Stock
vs
24.96%
Sector Avg
+272.4%
(Superior)
Debt to Equity
6.89
This Stock
vs
3.28
Sector Avg
+110.2%
(Higher)
Revenue Growth
546.1%
This Stock
vs
108.53%
Sector Avg
+403.2%
(Fast Growth)
Current Ratio
0.18
This Stock
vs
8.3
Sector Avg
-97.8%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
AGNCM
AGNC Investment Corp.
|
BEARISH | $8.88B | - | 15.1% | 92.9% | $24.99 | |
|
AGNCN
AGNC Investment Corp.
|
BEARISH | $8.8B | - | 15.1% | 92.9% | $25.63 | |
|
AHR
American Healthcare REIT, Inc.
|
BEARISH | $8.61B | 385.33 | 1.1% | 1.2% | $46.24 | |
|
ADC
Agree Realty Corporation
|
NEUTRAL | $8.36B | 42.18 | 3.5% | 28.1% | $72.55 | |
|
BRX
Brixmor Property Group Inc.
|
BEARISH | $8.08B | 24.23 | 11.4% | 24.7% | $26.41 |
Past News Coverage
Recent headlines mentioning AGNCM from our newsroom.
Newest → oldest
No matching news yet.